FFIV
61
4
GS
53
3
FLR
48
3
APD
44
2
C
44
3
HIG
66
2
AMP
57
3
CNP
73
2
BXP
44
3
CAH
64
3
AVGO
15
2
GD
63
11
AAL
20
5
FOXA
67
3
GM
50
-2
AVB
54
2
DAL
29
-7
AEP
75
-2
GLW
44
3
DVA
65
3
FFIV
61
4
GS
53
3
FLR
48
3
APD
44
2
C
44
3
HIG
66
2
AMP
57
3
CNP
73
2
BXP
44
3
CAH
64
3
AVGO
15
2
GD
63
11
AAL
20
5
FOXA
67
3
GM
50
-2
AVB
54
2
DAL
29
-7
AEP
75
-2
GLW
44
3
DVA
65
3
Financhill
Back

The Oncology Institute 10K Form

Buy
75

TOI
The Oncology Institute

Last Price:
$1.45
Seasonality Move:
-10.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $393.4M
Cash Flow: $2.4M
Price / Cash Flow: 0
Annual Sales: $0.05
Price / Book: 30.81

Profitability

EPS (TTM): -0.71000
Net Income (TTM): $-64.7M
Gross Margin: $54M
Return on Equity: -220.55%
Return on Assets: -34.2%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 6 years for TOI is 13.73%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 27.41% of Gross Profit Margin.
  • The Net Earning history of TOI is -16.44% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 25.95
Current Ratio: 2.15
Quick Ratio: 1.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Buy
75
The Oncology Institute (TOI) is a Buy

Is The Oncology Institute a Buy or a Sell?